Observational study of unrelated peripheral blood stem cell transplantation in Japan

Observational study of unrelated peripheral blood stem cell transplantation in Japan - Observational study of URPBSCT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005212

Enrollment

Registered

2011-03-08

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological malignant and benaign disease which are approved by Japanese Bone Marrow Program (JMDP)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients who meet the criteria of JMDP (hematological malignant and benign disease) and who receive unrelated peripheral blood stem cell transplantation from a HLA-A, B, C, DRB1 genotypically identical donor who is coordinated by JMDP.

Exclusion criteria

Exclusion criteria: All patients who does not meet the key inclusion criteria

Design outcomes

Primary

Measure	Time frame
Overall survival 100 days after transplantation for hematological malignant disease	—

Countries

Japan

Contacts

Public ContactJuinji Tanaka

Hokkaido University Graduate School of Medicine Department of Hematology and Oncology

jutanaka@med.hokudai.ac.jp011-706-7214

Outcome results